|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net (loss) income | ||||
| Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities: | ||||
| Depreciation and amortization | ||||
| Amortization of deferred financing costs | ||||
| Amortization of right-of-use assets | ||||
| Deferred income taxes | ||||
| Share-based compensation expense | ||||
| Allowance for credit losses | ||||
| Impairment loss on strategic investment | ||||
| Allowance for credit losses, net | ||||
| Loss on disposal of fixed assets | ||||
| Loss on extinguishment of debt | ||||
| Loss on change in fair value of warrant liabilities | ||||
| Amortization of fair value of warrants issued with debt | ||||
| Amortization of premium and discount on marketable securities | ||||
| Gain on previously held investment in LimFlow | ||||
| Changes in: | ||||
| Accounts receivable | ||||
| Inventories | ||||
| Prepaid expenses, deposits and other assets | ||||
| Accounts payable | ||||
| Payroll-related accruals, accrued expenses and other liabilities | ||||
| Operating lease liabilities | ||||
| Lease prepayments for lessor's owned leasehold improvements | ||||
| Net cash provided (used in) by operating activities | ||||
| Cash flows from investing activities | ||||
| Purchases of property and equipment | ||||
| Purchases of marketable securities | ||||
| Maturities of marketable securities | ||||
| Sales of marketable securities | ||||
| Purchases of other investments | ||||
| Net cash paid for acquisition | ||||
| Capitalized software development costs | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities | ||||
| Proceeds from issuance of common stock under employee stock purchase plan | ||||
| Proceeds from exercise of stock options | ||||
| Payment of taxes related to vested restricted stock units | ||||
| Proceeds from notes payable | ||||
| Repayments of notes payable | ||||
| Debt financing costs | ||||
| Proceeds from subscriptions receivable | ||||
| Net cash provided by financing activities | ||||
| Effect of foreign exchange rate on cash and cash equivalents | ||||
| Effect of foreign exchange rate on cash, cash equivalents and restricted cash | ||||
| Net decrease in cash, cash equivalents and restricted cash | ||||
| Cash, cash equivalents and restricted cash beginning of year | ||||
| Cash, cash equivalents and restricted cash end of year | ||||
| Cash paid for income taxes | ||||
| Cash paid for interest | ||||
| Lease liabilities arising from obtaining new right-of-use assets | ||||
| Common stock issued on conversion of convertible preferred stock | ||||
| Common stock warrants issued on conversion of preferred stock warrants and the reclassification of the warrant liability | ||||
| Deferred initial public offering cost recorded to additional paid in capital | ||||
| Accrual of deferred interest obligation associated with debt |
Loading...
